Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Dimetridazole
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
Interrogation of Chesapeake Bay sediment microbial communities for intrinsic alkane-utilizing potential under anaerobic conditions.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story. Exp Gerontol. 2015 Aug; 68:51-8.
View in:
PubMed
subject areas
Alzheimer Disease
Animals
Autophagy
Behavior, Animal
Cerebrovascular Circulation
Cognition Disorders
Disease Models, Animal
Longevity
Memory Disorders
Mice
Neurofibrillary Tangles
Plaque, Amyloid
Sirolimus
TOR Serine-Threonine Kinases
Vasodilator Agents
authors with profiles
Arlan G. Richardson